Mindfulness Training in Adolescents With Type 1 Diabetes

Mindfulness-based Stress Reduction in Adolescents With Type 1 Diabetes

Status

UNKNOWN

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT06140030

Enrollment

Registered

2023-11-18

Start date

2023-10-01

Completion date

2025-12-01

Last updated

2023-12-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Quality of Life, Type 1 Diabetes

Brief summary

Creation of an adaptation of a mindfulness-based stress reduction mobile health application specifically designed for adolescents living with Type 1 diabetes. Aim to determine whether daily mindfulness improves anxiety symptoms in adolescents with Type 1 diabetes.

Interventions

BEHAVIORALMindfulness training

Mindfulness-training mobile health application

Study design

Allocation

Intervention model

SINGLE_GROUP

Primary purpose

TREATMENT

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

12 Years to 19 Years

Healthy volunteers

Inclusion criteria

* Clinical diagnosis of Type 1 diabetes for 6 months or longer * Anxiety score of 5 or higher on the Generalized Anxiety Disorder 7-item scale * Must be able to read and speak English

Exclusion criteria

* Clinical diagnosis of a chronic medical condition requiring intensive daily management

Design outcomes

Primary

Measure	Time frame	Description
Anxiety Symptoms	12 weeks	Generalized Anxiety Disorder 7-item Score range: 0 to 21 Higher scores indicate more anxiety

Secondary

Measure	Time frame	Description
Diabetes-specific quality of life	12 weeks	Pediatric Quality of Life Inventory 3.2 Diabetes Module Range 0 to 100 Higher scores indicate better quality of life
Glycemic control	12 weeks	HbA1c

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026